Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
about
Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura.Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases.
P2860
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@ast
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@en
type
label
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@ast
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@en
prefLabel
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@ast
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@en
P2093
P2860
P1433
P1476
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
@en
P2093
Donald M Arnold
Jane Moore
John G Kelton
Vinai C Bhagirath
P2860
P304
P356
10.1111/J.1537-2995.2012.03635.X
P577
2012-04-04T00:00:00Z